BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22649191)

  • 1. GITR ligand provided by thrombopoietic cells inhibits NK cell antitumor activity.
    Placke T; Salih HR; Kopp HG
    J Immunol; 2012 Jul; 189(1):154-60. PubMed ID: 22649191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/tumor cell interactions.
    Baltz KM; Krusch M; Bringmann A; Brossart P; Mayer F; Kloss M; Baessler T; Kumbier I; Peterfi A; Kupka S; Kroeber S; Menzel D; Radsak MP; Rammensee HG; Salih HR
    FASEB J; 2007 Aug; 21(10):2442-54. PubMed ID: 17360848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid-induced tumor necrosis factor receptor-related protein ligand subverts immunosurveillance of acute myeloid leukemia in humans.
    Baessler T; Krusch M; Schmiedel BJ; Kloss M; Baltz KM; Wacker A; Schmetzer HM; Salih HR
    Cancer Res; 2009 Feb; 69(3):1037-45. PubMed ID: 19155305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
    Kopp HG; Placke T; Salih HR
    Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-induced TNFR-related protein (GITR) ligand modulates cytokine release and NK cell reactivity in chronic lymphocytic leukemia (CLL).
    Buechele C; Baessler T; Wirths S; Schmohl JU; Schmiedel BJ; Salih HR
    Leukemia; 2012 May; 26(5):991-1000. PubMed ID: 22064350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of natural killer cell anti-tumor reactivity by platelets.
    Placke T; Kopp HG; Salih HR
    J Innate Immun; 2011; 3(4):374-82. PubMed ID: 21411974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity.
    Kamimura Y; Iwai H; Piao J; Hashiguchi M; Azuma M
    J Immunol; 2009 Mar; 182(5):2708-16. PubMed ID: 19234165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of tumor cells by natural killer cells in mice is impeded by platelets.
    Nieswandt B; Hafner M; Echtenacher B; Männel DN
    Cancer Res; 1999 Mar; 59(6):1295-300. PubMed ID: 10096562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL).
    Hanabuchi S; Watanabe N; Wang YH; Wang YH; Ito T; Shaw J; Cao W; Qin FX; Liu YJ
    Blood; 2006 May; 107(9):3617-23. PubMed ID: 16397134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells.
    Placke T; Örgel M; Schaller M; Jung G; Rammensee HG; Kopp HG; Salih HR
    Cancer Res; 2012 Jan; 72(2):440-8. PubMed ID: 22127925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-induced tumor necrosis factor receptor family-related ligand triggering upregulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 and promotes leukocyte adhesion.
    Lacal PM; Petrillo MG; Ruffini F; Muzi A; Bianchini R; Ronchetti S; Migliorati G; Riccardi C; Graziani G; Nocentini G
    J Pharmacol Exp Ther; 2013 Oct; 347(1):164-72. PubMed ID: 23892569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets.
    Crist SA; Elzey BD; Ludwig AT; Griffith TS; Staack JB; Lentz SR; Ratliff TL
    Exp Hematol; 2004 Nov; 32(11):1073-81. PubMed ID: 15539085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura].
    Wang L; Zhang F; Zhu YY; Li LZ; Ma DX; Hou M
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3048-51. PubMed ID: 16324405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of glucocorticoid-induced tumor necrosis factor receptor family-related protein ligand (GITRL) induces inflammatory activation of microglia in culture.
    Hwang H; Lee S; Lee WH; Lee HJ; Suk K
    J Neurosci Res; 2010 Aug; 88(10):2188-96. PubMed ID: 20162721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets and P-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells.
    Coupland LA; Chong BH; Parish CR
    Cancer Res; 2012 Sep; 72(18):4662-71. PubMed ID: 22836751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirements for control of B-cell lymphoma by NK cells.
    Brenner CD; King S; Przewoznik M; Wolters I; Adam C; Bornkamm GW; Busch DH; Röcken M; Mocikat R
    Eur J Immunol; 2010 Feb; 40(2):494-504. PubMed ID: 19950185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human NK cell activation/inhibition threshold allows small changes in the target cell surface phenotype to dramatically alter susceptibility to NK cells.
    Holmes TD; El-Sherbiny YM; Davison A; Clough SL; Blair GE; Cook GP
    J Immunol; 2011 Feb; 186(3):1538-45. PubMed ID: 21191066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal human dendritic cell-natural killer cell interactions induce antitumor activity following tumor cell infection by oncolytic reovirus.
    Prestwich RJ; Errington F; Steele LP; Ilett EJ; Morgan RS; Harrington KJ; Pandha HS; Selby PJ; Vile RG; Melcher AA
    J Immunol; 2009 Oct; 183(7):4312-21. PubMed ID: 19734207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-expressed immune checkpoint regulator GITRL in breast cancer.
    Zhou Y; Heitmann JS; Clar KL; Kropp KN; Hinterleitner M; Engler T; Koch A; Hartkopf AD; Zender L; Salih HR; Maurer S; Hinterleitner C
    Cancer Immunol Immunother; 2021 Sep; 70(9):2483-2496. PubMed ID: 33538861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of GITR ligand abrogates immunosuppressive function of ocular tissue and differentially modulates inflammatory cytokines and chemokines.
    Mahesh SP; Li Z; Liu B; Fariss RN; Nussenblatt RB
    Eur J Immunol; 2006 Aug; 36(8):2128-38. PubMed ID: 16874737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.